biology

Ansa Biotechnologies wants to usher in a new era of DNA manufacturing

Daniel Arlow has spent the last eighteen years studying genomics and synthetic biology. The arc of his career has taken the first-time founder of the new startup Ansa Biotechnologies from MIT to the f

This looping aquatic treadmill lets tiny ocean creatures swim forever under the microscope

Observing the microscopic creatures that fill our oceans is important work, but keeping your eye on one in the wild is practically impossible — and doing so in a dish isn’t the same. This &#82

Mission Bio raises $70 million to help scale its tech for improving the development of targeted cancer therapies

California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and A

Mammoth Biosciences lands exclusive license to new CRISPR proteins that could boost gene editing precision

CRISPR pioneer Mammoth Biosciences has secured an exclusive license to a new family of CRISPR proteins. Obtained from UC Berkeley, the license covers R&D and commercialization across all potential

Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) program on Friday. Mammoth re

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

Cue Health’s portable, fast COVID-19 test gains FDA emergency approval

Fresh off a $100 million Series C funding round, molecular diagnostics startup Cue Health has more good news — it has received an Emergency Use Authorization (EUA) for its rapid, point-of-care COVID

Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery

Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuti

How will coronavirus change the world? — Parlia launches to help you find out

“Is Greta Thunberg a hypocrite?” Google that phrase and you will get thousands of results. It just goes to show that, to a large extent, the “Q&A” model is broken on the internet.

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic

Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Admin

Curative received FDA emergency use authorization for its novel COVID-19 tests

The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. The company says that its tests h

Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test

SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. Th

Pinterest CEO and a team of leading scientists launch a self-reporting COVID-19 tracking app

There have been a few scattered efforts to leverage crowd-sourced self-reporting of symptoms as a way to potentially predict and chart the progress of COVID-19 across the U.S., and around the world. A

Aspen Neuroscience raises $70M for its experimental Parkinson’s Disease treatment

Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for Parkinson Disease. No

Cell and gene therapy startup ElevateBio raises $170M

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant mone

Nonprofit aims to get COVID-19 field tests, N95 masks and more to healthcare workers without markups

A new Sydney-based nonprofit volunteer organization called RapidWard launched this week, with a focus on getting critical medical supplies from producers in China to healthcare professionals, doctors,

Justice Dept. files its first coronavirus takedown: a bogus vaccine website

U.S. federal prosecutors have filed and won a temporary restraining order against a website offering a fraudulent coronavirus vaccine, which the Justice Department said is its first enforcement action

Nvidia makes its GPU-powered genome sequencing tool available free to those studying COVID-19

Nvidia is making its Parabricks tool available for free for 90 days (with the possibility of extension, depending on needs) to any researcher currently working on any effort to combat the ongoing nove

Oxford scientists develop new coronavirus test that provides results in just 30 minutes

Scientists at the University of Oxford have developed a new coronavirus test that produces results around three times faster than the current fastest testing methods, and that requires only relatively

As national COVID-19 cases top 1,000, insurers waive treatment fees and US preps stimulus

The number of COVID-19 cases in the U.S. crossed 1,000 on Tuesday as President Donald Trump met with the nation’s largest insurers and members of his cabinet to discuss how to pay for treatment
Load More